Increase/Decrease in Cash: The total change in cash for the company over the given period.
Alzamend Neuro, Inc. (ALZN) had Increase/Decrease in Cash of $-4.86M for the most recently reported fiscal quarter, ending 2024-01-31.
| Income Statement Financials | |
-- |
|
$-2.66M |
|
-- |
|
-- |
|
$2.66M |
|
$-2.66M |
|
$-0.00M |
|
$-2.66M |
|
$-2.66M |
|
$-2.66M |
|
$-2.66M |
|
$-2.66M |
|
$-2.66M |
|
$-2.66M |
|
$-2.65M |
|
7.05M |
|
7.05M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$0.59M |
|
$0.19M |
|
$0.19M |
|
$0.78M |
|
$3.83M |
|
-- |
|
$1.22M |
|
$5.05M |
|
$-4.26M |
|
$-4.26M |
|
$-4.26M |
|
6.62M |
|
| Cash Flow Statement Financials | |
$-6.84M |
|
$-0.15M |
|
$2.13M |
|
$5.14M |
|
$0.28M |
|
|
Increase/Decrease in Cash |
$-4.86M |
$0.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.99M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
62.44% |
|
62.44% |
|
-340.19% |
|
62.44% |
|
$-0.64 |
|
$-0.99 |
|
$-0.97 |
|